Long-Term Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: An Italian Multicenter Collaborative Study
Open Access
- 18 June 2025
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 31 (10) , 806.e1-806.e19
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- CAR T Cells and T-Cell Therapies for CancerJAMA, 2024
- Allogeneic stem cell transplantation and CAR-T in B-cell Non-Hodgkin Lymphoma: a two-center experience and review of the literatureAnnals of Hematology, 2024
- Allogeneic Hematopoietic Stem Cell Transplant for Diffuse Large B-Cell Lymphoma: Evolving Role in the Era of CAR T-Cell TherapyCurrent Oncology Reports, 2023
- Real‐world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B‐cell lymphomaCancer Medicine, 2021
- Is It Time to Revisit the Role of Allogeneic Transplantation in Lymphoma?Current Oncology Reports, 2019
- Impact of Pretransplantation 18F-fluorodeoxy Glucose–Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin LymphomaTransplantation and Cellular Therapy, 2015
- Allotransplantation for Patients Age ≥40 Years with Non-Hodgkin Lymphoma: Encouraging Progression-Free SurvivalTransplantation and Cellular Therapy, 2014
- Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: A GITMO studyAnnals of Hematology, 2012
- Reduced-Intensity Conditioning Regimen Workshop: Defining the Dose Spectrum. Report of a Workshop Convened by the Center for International Blood and Marrow Transplant ResearchTransplantation and Cellular Therapy, 2009
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group ReportTransplantation and Cellular Therapy, 2005